NCT06803615Active, not recruiting
Noninvasive Mapping Before Surgical Ablation
The Use of Beat-to-Beat Noninvasive 3D Mapping to Study Patients Candidates for Concomitant Surgical Ablation for Persistent and Long-standing Persistent Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 29 Jun 2025
Brief summary (registry, in English)
The purpose of this study is to assess the electrophysiological mechanism of atrial fibrillation by means of a beat-to-beat noninvasive 3D mapping method in patients with concomitant persistent and long-standing persistent atrial fibrillation undergoing surgical ablation.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 51 (actual)
- First submitted
- 27 Jan 2025
- Start date
- 13 Jan 2017
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- Medical University of Vienna
- Diseases
- Atrial fibrillation
- NCT number
- NCT06803615
What you commit to
- Study type: Observational
- Participants enrolled: 51
- From 13 Jan 2017 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- any previous surgical ablation
- acute surgical indications
Other illness
- any physical condition that leads to a life expectancy of less than two years
- any contraindication to the treatments necessary for the trial's conduction as e.g.
- known allergic reaction to contrast agent
- known allergic reaction to antiarrhythmic drugs
- claustrophobia or anxiety in small spaces
- severe renal impairment
- unmanageable hyperthyroidism
Other
- vulnerable patient groups
- pregnancy
- participation in any other clinical trial that either excludes enrolment or may be a confounding factor to results
- voluntary retention
Who the study is looking for
- legal age (18-90a)
- life expectancy \> 2 years
- patients suffering from persistent and long standing atrial fibrillation
- scheduled for concomitant surgical ablation
- possibility to follow-up
- given informed consent
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Vienna Coordinator of this site? Confirm its status | Vienna | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.